Peri-implantitis, Comparing Treatments 970 nm Laser and Mucosal Flap Surgery

Comparing Treatment of Peri-implantitis With Either 970 nm Laser or Conventional Mucosal Flap Surgery - a Prospective Randomized Controlled Trial

A clinical trial comparing laser treatment and conventional mucosal flap surgery for treatment of peri-implantitis. The main aim of the study is to evaluate if treatment of peri-implantitis with 970 nm laser combined with scaling and root planning (SRP) is clinically comparable to conventional mucosal flap surgery in terms of pocket probing depth reduction.

Study Overview

• Status: Completed
• Conditions: Peri-Implantitis
• Intervention / Treatment: Device: Laser treatment; Behavioral: Oral hygiene instructions; Procedure: Mucosal flap surgery

Detailed Description

The present project aims to evaluate a novel method in treating peri-implantitis, with focus on decreasing the patient's suffering as well as disease progression. Peri-implantitis has a direct influence on both physical and psychological wellbeing and have been related to difficulty in chewing due to loss of implants, bad esthetic appearance as well as high costs. Therefore, it is of importance for the individual as well as for the society to thoroughly investigate any new treatment approaches.

The study is a prospective randomized clinical trial comparing laser treatment (test group) and conventional mucosal flap surgery (active control group). Assessment of clinical variables at baseline and after 6 months. Patient reported outcomes at baseline, directly after treatment and after 10 days.

Primary Objective:

To evaluate if treatment of peri-implantitis with 970 nm laser combined with scaling and root planning (SRP) is clinically comparable to conventional mucosal flap surgery in terms of pocket probing depth reduction.

Secondary Objectives:

• To evaluate other clinical and radiological variables connected to peri-implantitis and the inflammation surrounding the dental implant.
• To evaluate the patient experience of treatment of peri-implantitis.
• To evaluate the inflammatory and microbial response after laser treatment

• Study Type: Interventional
• Enrollment (Actual): 26
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Sweden
  • Stockholms Län
    • Danderyd, Stockholms Län, Sweden, 18231
      • Danakliniken Specialist Dentistry
    • Huddinge, Stockholms Län, Sweden, 14152
      • Specialist Dentistry Clinic, Karolinska Institutet, Dept. of Dental Medicine

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Signs of peri-implantitis around one or more dental implants. All criteria below need to be fulfilled for inclusion.

  • Presence of pocket probing depth (PPD) > 5 mm
  • Bleeding on probing/suppuration (BOP/Pus)
  • At least 2 mm loss of bone, visible on radiographs, after initial osseointegration.
• ≥ 18 years old.
• Patient able to understand Swedish.

Exclusion Criteria:

• Antibiotic treatment 6 months prior to baseline.
• Peri-implant treatment 6 months prior to baseline.
• Myocardial infarction 6 months prior to baseline.
• Previous radiation treatment in the affected jaw area.
• Previous i.v. bisphosphonate treatment.
• Moderate or severe impairment of cognitive function (e.g. dementia).

Study Plan

How is the study designed?

Design Details

• Primary Purpose: TREATMENT
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: SINGLE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: Laser treatment; Laser treatment with diode laser 970nm and settings 1.2W in intervals of max 20s, until satisfactory removal of diseased epithelium and granulation tissue.	Device: Laser treatment; The participants in the laser group are treated with a 970 nm diode laser and if calculus is present scaling and root planning (SRP). The peri-implant pocket will be radiated with the 970 nm laser, removing bacteria, diseased epithelium and granulation tissue. The laser will be used at a maximum of 20s intervals before water irrigation. Laser settings continuous wave mode and power between 1.0-1.3W. Total treatment time will vary with the depth of the pocket and size of the surrounding bone crater.; Behavioral: Oral hygiene instructions; Oral hygiene instructions of how to clean around dental implants as per individual needs in terms of access to clean and fine motor skills.
ACTIVE_COMPARATOR: Mucosal flap surgery; Conventional mucosal flap surgery of affected dental implant.	Behavioral: Oral hygiene instructions; Oral hygiene instructions of how to clean around dental implants as per individual needs in terms of access to clean and fine motor skills.; Procedure: Mucosal flap surgery; The participants will receive a conventional peri-implant mucosal flap surgery of affected implants, and return after 7-10 days for suture removal. The surgery is a well-established treatment of peri-implantitis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Mean change in pocket probing depth (PPD)	Pocket probing depth (PPD) will be measured by a 1 mm graded pocket probe from the bottom of the peri-implant pocket to the marginal mucosa and will be registered on 4 surfaces surrounding the implant.	0-6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Mean change in plaque index (PI)	Plaque index (PI) will be measured at 4 sites per implant and assessed as per cent of the total amount of measured implant surfaces.	0-6 months
Mean change in bleeding on probing (BOP)	BOP will be registered on 4 surfaces surrounding the implant after probing the peri-implant pocket with a pocket probe, up to 20 s after the provocation with the probe.	0-6 months
Mean change in presence of suppuration	Presence of suppuration will be registered on 4 surfaces surrounding the implant after probing the peri-implant pocket with a pocket probe, up to 20 s after the provocation with the probe.	0-6 months
Mean change in marginal bone level on radiographs	Measured on radiographs for a fixed point on the dental implant to the marginal bone level.	0-6 months
Mean change in inflammatory response in peri-implant crevicular fluid (PICF)	Analysis of inflammatory meditators in PICF will be performed by commercially available ELISAs or multiplex assays at base line and 6 months. The analytes of interest to be tested are mainly inflammatory cytokines, chemokines, growth factors, proteases, and molecules related to bone remodeling such as for IL-1β, MMP 8, TIMP-1, CSF-1, elastase activity, and RANK-L/OPG ratio.	0-6 months
Mean change in inflammatory response in saliva	Analysis of inflammatory meditators in stimulated saliva will be performed by commercially available ELISAs or multiplex assays at base line and 6 months. The analytes of interest to be tested are mainly inflammatory cytokines, chemokines, growth factors, proteases, and molecules related to bone remodeling such as for IL-1β, MMP 8, TIMP-1, CSF-1, elastase activity, and RANK-L/OPG ratio.	0-6 months
Composition of the subgingival microflora	The bacterial composition in the subgingival microflora will be analyzed by quantitative real-time Polymerase Chain Reaction (qPCR).	0-6 months
Mean change in patient reported outcome using the visual analogue scale (VAS) score	Visual analogue scale (VAS) is used to record the patients pain, discomfort and satisfaction with the treatment. The patients mark their response on a 100 mm line, with low values being no feeling of pain, discomfort or satisfaction, and high values meaning maximum pain, discomfort or satisfaction.	Baseline, directly after treatment, 10 days after and 6 months after treatment.

Collaborators and Investigators

• Sponsor: Karolinska Institutet
• Investigators: Principal Investigator: Annsofi Johannsen, Karolinska Institutet

Study record dates

Study Major Dates

• Study Start (ACTUAL): September 25, 2019
• Primary Completion (ACTUAL): June 21, 2022
• Study Completion (ACTUAL): June 21, 2022

Study Registration Dates

• First Submitted: October 16, 2019
• First Submitted That Met QC Criteria: January 29, 2020
• First Posted (ACTUAL): January 30, 2020

Study Record Updates

• Last Update Posted (ACTUAL): November 18, 2022
• Last Update Submitted That Met QC Criteria: November 16, 2022
• Last Verified: November 1, 2022

More Information

Terms related to this study

• Keywords: Patient reported outcomes; Immunology; Randomized controlled trial; Peri-implantitis; Microbiology; Surgical treatment; Clinical outcomes; Laser treatment
• Additional Relevant MeSH Terms: Stomatognathic Diseases; Periodontal Diseases; Mouth Diseases; Peri-Implantitis
• Other Study ID Numbers: Peri-implantitis 970 nm laser

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No